Leading Cancer Doctor Drops The Hammer On Huge Chemo Scam: Says Chemotherapy Is Actually More Deadly Than Cancer (VIDEO)

Credit: healthawarenessforall.com

This Changes Everything: Leading Cancer Doc Drops Hammer Of Truth On Chemo-Peddlers, Says They Kill More Patients Than Cancer Itself

Twelve and a half years. That’s how much time you have if you say no to something that everyone in the world is going to say you should accept.

According to Dr. Hardin B. Jones, you have to live on average if you are a cancer sufferer who refuses instead of accepts chemotherapy. We’ll get into Dr. Jones’s study of cancer and chemotherapy, but first a few statistics: 50 percent of men and 33 percent of women will develop cancer in their lifetimes.

Whether this is merely the sad truth due to our horrid diets, or the toxic pollution in our air, water and land, or the plastics we touch and which touch our food is hard to say definitively. It may well be a combination of all the above, perhaps also tinged with the simple fact that we are living far longer than our ancestors did even a hundred years ago.

But one fact that Dr. Jones believes he can prove is that chemo kills.

A former professor of medical physics and physiology at the University of California, Berkeley has published a study in the New York Academy of Science journal Transactions showing that the consequences of chemotherapy are often death than a cure.

“People who refused chemotherapy treatment live on average 12 and a half years longer than people who are undergoing chemotherapy,” said Dr. Jones. “People who accepted chemotherapy die within three years of diagnosis, a large number dies immediately after a few weeks.”

So if this is true, why is chemotherapy still the most widely accepted treatment for people suffering from cancer? Why hasn’t the medical community risen up against what appears to be a monstrous form of torture that, as Dr. Jones says, kills more often than it cures?

As with most things in the massive multi-trillion dollar industry that modern medicine has become, you can find a probable answer to this question if you follow the money. An average course of cancer treatment will run you between $300,000 and a cool million.

Yet where does all this money go? Despite the fact that healthcare spending in the United States is greater than any other nation in the world, we still have a shorter life expectancy than in much of the world. When it comes to cancer, Dr. Jones says there are simple facts that back him up, facts the mainstream media don’t want you to know.

“Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system,” he says. “So this is something that you will not hear in the mass media, which will continue to carry the myth that the best chemotherapy drug in the fight against cancer!”

What you will hear about constantly is a bombardment of ads for sugary, fatty foods that make our corporate masters more profit than natural foods, once again proving that anything that can be packaged and sold will be, no matter the consequences to people–just like chemotherapy.

Coincidence? Maybe. But probably not.

YOU TUBE VIDEO

Berkeley Doctor Claims People Die From Chemotherapy, Not Cancer [Watch]

1
Leave a Reply

avatar
1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
1 Comment authors
George Meredith MD Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
George Meredith MD
Guest
George Meredith MD

George Meredith MD This is but the tip of the iceberg! Consider: the breast cancer death rate per 100,000 US women is essentially the same today as it was in 1970. The treatment then was some type of mastectomy and adjunctive radiotherapy (hopefully 5000 Rads as opposed today’ more dangerous 6500 Rads). Surgeons knew back then that adjunctive chemotherapy did not appreciably improve the 5 and 10 year survival rates and so no adjunctive chemotherapy was given back then. Today, we have genetic testing, the Cancer Treatment Centers of America, a plethora of adjunctive chemotherapeutic agents and a host of… Read more »